A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults

This study describes a double-blind randomized placebo-controlled phase I clinical trial in healthy adults of a new potential pandemic H7N9 live attenuated influenza vaccine (LAIV) based on the human influenza virus of Yangtze River Delta hemagglutinin lineage (ClinicalTrials.gov Identifier: NCT0373...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiseleva, Irina, Isakova-Sivak, Irina, Stukova, Marina, Erofeeva, Marianna, Donina, Svetlana, Larionova, Natalie, Krutikova, Elena, Bazhenova, Ekaterina, Stepanova, Ekaterina, Vasilyev, Kirill, Matyushenko, Victoria, Krylova, Marina, Galatonova, Julia, Ershov, Aleksey, Lioznov, Dmitry, Sparrow, Erin Grace, Torelli, Guido, Rudenko, Larisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350028/
https://www.ncbi.nlm.nih.gov/pubmed/32532097
http://dx.doi.org/10.3390/vaccines8020296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350028/
https://www.ncbi.nlm.nih.gov/pubmed/32532097
http://dx.doi.org/10.3390/vaccines8020296

Ejemplares similares